alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS ON PAGES TWO AND THREE
OF THE COMPANY'S FORM 10-Q FOR THE YEAR TO DATE AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                       3,062,789
<SECURITIES>                                         0
<RECEIVABLES>                               26,867,620
<ALLOWANCES>                               (2,098,211)
<INVENTORY>                                          0
<CURRENT-ASSETS>                            38,705,043
<PP&E>                                      23,763,549
<DEPRECIATION>                             (2,922,772)
<TOTAL-ASSETS>                             120,638,437
<CURRENT-LIABILITIES>                       22,235,585
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        62,983
<OTHER-SE>                                  77,017,209
<TOTAL-LIABILITY-AND-EQUITY>               120,638,437
<SALES>                                      6,381,611
<TOTAL-REVENUES>                            23,595,037
<CGS>                                        1,895,057
<TOTAL-COSTS>                               19,396,996
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                               663,934
<INTEREST-EXPENSE>                             876,782
<INCOME-PRETAX>                              4,804,693
<INCOME-TAX>                                 1,777,736
<INCOME-CONTINUING>                          3,026,957
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,026,957
<EPS-BASIC>                                        .41
<EPS-DILUTED>                                      .40


</TABLE>
# Official Journal L 305/2019

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 305 |
| | |
| English edition | Legislation | Volume 6226 November 2019 |

ISSN 1977-0677

Official Journal

of the European Union

L 305

English edition

Legislation

Volume 6226 November 2019

---

| Contents | | I   Legislative acts | page |
| --- | --- | --- | --- |
| | | DIRECTIVES |
| | * | Directive (EU) 2019/1936 of the European Parliament and of the Council of 23 October 2019 amending Directive 2008/96/EC on road infrastructure safety management | 1 |
| | * | Directive (EU) 2019/1937 of the European Parliament and of the Council of 23 October 2019 on the protection of persons who report breaches of Union law | 17 |

Contents

I   Legislative acts

page

DIRECTIVES

*

Directive (EU) 2019/1936 of the European Parliament and of the Council of 23 October 2019 amending Directive 2008/96/EC on road infrastructure safety management

1

*

Directive (EU) 2019/1937 of the European Parliament and of the Council of 23 October 2019 on the protection of persons who report breaches of Union law

17

| | | II   Non-legislative acts |
| --- | --- | --- |
| | | DECISIONS |
| | * | Decision (EU) 2019/1938 of the European Parliament and of the Council of 18 September 2019 on the mobilisation of the European Globalisation Adjustment Fund (EGF/2019/000 TA 2019 — Technical assistance at the initiative of the Commission) | 57 |

II   Non-legislative acts

DECISIONS

*

Decision (EU) 2019/1938 of the European Parliament and of the Council of 18 September 2019 on the mobilisation of the European Globalisation Adjustment Fund (EGF/2019/000 TA 2019 — Technical assistance at the initiative of the Commission)

57

| | | Corrigenda |
| --- | --- | --- |
| | * | Corrigendum to Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on organic production and labelling of organic products and repealing Council Regulation (EC) No 834/2007 ( OJ L 150, 14.6.2018 ) | 59 |

Corrigenda

*

Corrigendum to Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on organic production and labelling of organic products and repealing Council Regulation (EC) No 834/2007 ( OJ L 150, 14.6.2018 )

59

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
<PAGE>

                                                                    EXHIBIT 32.1

           CERTIFICATIONS PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
                    RULE 13a-14(b) AND 18 U.S.C. SECTION 1350

In connection with the Annual Report on Form 10-K of Crowley Maritime
Corporation (the "Company") for the fiscal year ended December 31, 2005, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), Thomas B. Crowley, Jr., Chairman of the Board, President and Chief
Executive Officer of the Company, and John C. Calvin, Senior Vice President and
Controller of the Company, each certifies for the purpose of complying with Rule
13a-14(b) under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), and Section 1350 of Chapter 63 of title 18 of the United States Code, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) the Report fully complies with the requirements of Section 13(a) or
      15(d) of the Exchange Act; and

      (2) the information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.

Date: March 17, 2006             /s/ Thomas B. Crowley, Jr.
                                 --------------------------------------------
                                 Thomas B. Crowley, Jr.
                                 Chairman of the Board,
                                 President and Chief Executive Officer

Date: March 17, 2006             /s/ John C. Calvin
                                 --------------------------------------------
                                 John C. Calvin
                                 Senior Vice President and Controller
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                           JUL-1-2000              JUL-3-1999
<PERIOD-START>                              JUL-4-1999             JUN-29-1997
<PERIOD-END>                                OCT-2-1999             SEP-26-1998
<CASH>                                          59,490                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  457,491                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    463,533                       0
<CURRENT-ASSETS>                             1,036,556                       0
<PP&E>                                         457,234                       0
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                               2,157,133                       0
<CURRENT-LIABILITIES>                          546,117                       0
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                           0                       0
<TOTAL-LIABILITY-AND-EQUITY>                 2,157,133                       0
<SALES>                                      1,682,833               1,478,370
<TOTAL-REVENUES>                             1,682,833               1,478,370
<CGS>                                        1,371,134               1,208,393
<TOTAL-COSTS>                                  258,568                 224,938
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              14,641                  16,196
<INCOME-PRETAX>                                  3,840                  28,843
<INCOME-TAX>                                    15,427                  11,931
<INCOME-CONTINUING>                             23,113                  16,912
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    23,113                  16,912
<EPS-BASIC>                                       0.23                    0.18
<EPS-DILUTED>                                     0.23                    0.18



</TABLE>
Exhibit 99.5


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Wyeth (the "Company") on Form 10-K/A for
the fiscal year ended December 31, 2001, as filed with the Securities and
Exchange Commission on December 23, 2002 (the "Report"), I, Kenneth J. Martin,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.




Dated:  December 23, 2002                By /s/  Kenneth J. Martin
                                            ---------------------------
                                                 Kenneth J. Martin
                                              Executive Vice President
                                            and Chief Financial Officer
[641 NYS2d 536]

#### In the Matter of Henry William Archer (Admitted as Henry W. Arachtingi), an Attorney, Respondent. Departmental Disciplinary Committee for the First Judicial Department, Petitioner.

First Department,

April 11, 1996

APPEARANCES OF COUNSEL

*Jeremy S. Garber*of counsel *(Hal R. Lieberman,*attorney), for petitioner.

No appearance for respondent.

OPINION OF THE COURT

Per Curiam.

Respondent was admitted to practice at the First Judicial Department in 1956, under his former name, Henry W. Arachtingi. On October 20, 1995, this Court directed a psychiatric ex*306amination to aid in determining whether respondent was "incapacitated from continuing to practice law by reason of mental infirmity or illness.”

The record in this case reveals several instances of intemperate, disrespectful, and occasionally threatening behavior directed at Judges, opposing counsel and Disciplinary Committee personnel (the chairman, chief counsel and staff members), since 1990. Respondent has been under sporadic psychiatric care since 1994, with two brief hospitalizations in late 1995. He has been medically maintained on the antidepressant Nardil.

Pursuant to this Court’s order, respondent underwent psychiatric evaluation by Dr. Amy S. Hoffman at Elmhurst Hospital Center. Dr. Hoffman’s preliminary review of the files furnished by petitioner revealed graphic instances of respondent’s "vehement and hostile tone and * * * paranoid thinking which borders on the delusional.” Respondent admitted to multiple episodes of depression and fatigue over the last 11 years, relieved only by medication that raises him to an "elevated state” from which he occasionally overreacts to perceptions of injustice. Although he was loathe to speak about his thoughts at the moments of his intemperate remarks, it was clear to the psychiatrist that "at times he is paranoid with persecutory thinking and preoccupation.” These mood swings are interrupted by significant periods of more normal functioning, but "recurrence of the active phase of illness is unpredictable”, and respondent has refused to remain in treatment or agree to a plan of monitoring the symptoms of his illness. As a consequence, Dr. Hoffman concluded that respondent’s "insight and judgment are sufficiently impaired by his illness to prevent him from the effective practice of law.”

Accordingly, the petition should be granted and respondent should be suspended from the practice of law, on the ground of incapacitation by reason of mental infirmity, for an indefinite period and until further order of this Court (22 NYCRR 603.16).

Rosenberger, J. P., Wallach, Rubin, Tom and Mazzarelli, JJ., concur.

Application granted, and respondent suspended from practice as an attorney and counselor-at-law in the State of New York indefinitely, effective April 11, 1996, and until the further order of this Court.
---

Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Dutch Gold Resources, Inc.  (the "Company") on Form 10-Q for the period ending June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve Keaveney, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:





(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and





(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





Date: August 11, 2010
/s/ Steve KeaveneyName:  Steve Keaveney

Title:  Chief Financial Officer

(Principal d Financial Officer)





This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                      32,859,478
<SECURITIES>                                         0
<RECEIVABLES>                               11,889,785
<ALLOWANCES>                                         0
<INVENTORY>                                  7,171,007
<CURRENT-ASSETS>                            70,494,111
<PP&E>                                      47,758,178
<DEPRECIATION>                              33,106,026
<TOTAL-ASSETS>                              91,948,160
<CURRENT-LIABILITIES>                       52,429,709
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       444,309
<OTHER-SE>                                  31,002,332
<TOTAL-LIABILITY-AND-EQUITY>                91,948,160
<SALES>                                    103,660,137
<TOTAL-REVENUES>                           103,660,137
<CGS>                                       78,658,573
<TOTAL-COSTS>                               96,052,843
<OTHER-EXPENSES>                               381,379
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           3,451,066
<INCOME-PRETAX>                              5,696,713
<INCOME-TAX>                                   891,230
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,805,483
<EPS-PRIMARY>                                     1.08
<EPS-DILUTED>                                     1.08



</TABLE>
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

VICTOR GOMEZ,

Appellant,

v.

THE STATE OF TEXAS,

Appellee. §

§

§

§

§

§ No. 08

- 12

- 00001

- CR

Appeal from the

Criminal District Court Number One

of El Paso County, Texas

(TC#20110D04048)

J U D G M E N T

The Court has considered this cause on the record and concludes there was no error in the

judgment. We therefore affirm the judgment of the court below. This decision shall be certified

below for observance.

IT IS SO ORDERED THIS 11TH DAY OF JULY, 2014.

GUADALUPE RIVERA, Justice

Before McClure, C.J., Rivera, and Rodrigue z, JJ.
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO****SECTION 1350, CHAPTER 63 OF TITLE 18, UNITEDSTATES CODE,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Pursuant to Section 1350, Chapter 63 of Title 18, Untied StatesCode, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, the undersigned, the President and Chief Executive Officer of AmericanScience & Engineering, Inc. (the “Company”), does hereby certifythat to the undersigned’s knowledge:

 

1.                                       the Company’sAnnual Report on Form 10-K/A for the year ended March 31, 2004 (“10-K/A”)fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2.                                       the informationcontained in the Company’s 10-K/A being filed fairly presents, in all materialrespects, the financial condition and results of operation of the Company.

 

 
| Date**: February 15, 2005** | /s/ ANTHONY R. FABIANO                  |   |
|-----------------------------|-----------------------------------------|--------|
|                        | Anthony R. Fabiano                      |
|                        | *President and Chief Executive Officer* |

 

A signed original of this written statement required by Section 906has been provided to American Science & Engineering, Inc. andwill be retained by American Science & Engineering, Inc. andfurnished to the Securities and Exchange Commission or its staff upon request.

 

----
EXHIBIT
        4.13

AMENDMENT NO. 1

THIS
        AGREEMENT made the 28th day of March, 2008.

BETWEEN:

ONCOLYTICS BIOTECH INC.

(“Oncolytics”)



- and
        -



KARL L. METTINGER, M.D., Ph.D

(the
        “Employee”)

WHEREAS Oncolytics and the Employee entered into an Executive Employment
        Agreement dated the 29th day of May, 2007 (the “Employment
        Agreement)”

AND WHEREAS the parties wish to amend the Employment Agreement;

NOW THEREFORE the parties agree as follows:

Section 1 –Amendments

The Employment Agreement is hereby amended:

| | (a) | by replacing Section 3(1) with the following:
| | --- | ---------------------------------------------

“Commencing January 1, 2008, Oncolytics shall pay to the Employee
        a salary of THREE HUNDRED EIGHTEEN THOUSAND TWO HUNDRED AND SEVENTY UNITED STATES DOLLARS
        (US$318,270.00) per annum, exclusive of bonuses, benefits and other compensation, payable
        in equal installments of TWENTY-SIX THOUSAND FIVE HUNDRED TWENTY-TWO UNITED STATES DOLLARS
        AND FIFTY CENTS (US$26,522.50) on the last day of each month.”

| | (b) | by replacing Section 4 with the following:
| | --- | ------------------------------------------



“The Employee shall be entitled to payment in lieu of employment
        benefits (medical, dental, etc,) of a total of THIRTY EIGHT THOUSAND EIGHT HUNDRED AND
        NINETY-SIX UNITED STATES DOLLARS AND TWENTY CENTS (US$38,896.20)
        annually, payable pro rata with the Employee’s monthly payment of
        salary.”



Section 2 - Effective Date

|(1) | This Amending Agreement shall be effective from and after
                    January 1, 2008.
|--- | ----------------------------------------------------------------------------------------------

(2)
        In all other respects the parties confirm that the Employment Agreement, as
        amended, shall remain in full force and effect.

---

IN WITNESS WHEREOF the parties have executed this Agreement as of the day
        and year first above written.

ONCOLYTICS BIOTECH INC.



Per:
        /s/ Brad
        Thompson

| | Brad Thompson President & CEO
| | -----------------------------





Per:
        /s/ Doug
        Ball

| | Doug Ball               | 
| | ----------------------- | 
| | Chief Financial Officer



|                                        |                                          
|--------------------------------------- | -----------------------------------------
|/s/ Debbie
                    McClusky | /s/ Karl L.
                    Mettinger
|WITNESS                                 |                                          

-2-

---